167 related articles for article (PubMed ID: 31566792)
1. Does treatment with propranolol affect quality of life in infantile hemangioma patients and their parents?
de Wild SR; Moyakine AV; van der Vleuten CJM
Pediatr Dermatol; 2019 Nov; 36(6):958-960. PubMed ID: 31566792
[TBL] [Abstract][Full Text] [Related]
2. Parental experiences with propranolol versus oral corticosteroids for complicated infantile hemangioma, a retrospective questionnaire study.
Hermans DJ; Zweegers J; Evers AW; Van Der Vleuten CJ
Eur J Dermatol; 2013; 23(6):857-63. PubMed ID: 24185746
[TBL] [Abstract][Full Text] [Related]
3. Influence of infantile hemangioma severity and activity on QoL of patients and their parents: A cross-sectional study.
Moyakine AV; Spillekom-van Koulil S; Küpers EM; van der Vleuten CJM
Pediatr Dermatol; 2018 Sep; 35(5):628-634. PubMed ID: 30015356
[TBL] [Abstract][Full Text] [Related]
4. Propranolol for treatment of infantile hemangiomas.
Melo JN; Rotter A; Rivitti-Machado MC; Oliveira ZN
An Bras Dermatol; 2013; 88(6 Suppl 1):220-3. PubMed ID: 24346925
[TBL] [Abstract][Full Text] [Related]
5. Symplastic hemangioma developing over an infantile hemangioma during propranolol treatment.
Downey C; Pino G; Zambrano MJ; Kramer D; Cervilla K; González S
Pediatr Dermatol; 2019 Nov; 36(6):961-962. PubMed ID: 31468563
[TBL] [Abstract][Full Text] [Related]
6. The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol.
Castaneda S; Melendez-Lopez S; Garcia E; De la Cruz H; Sanchez-Palacio J
Adv Ther; 2016 Oct; 33(10):1831-1839. PubMed ID: 27461120
[TBL] [Abstract][Full Text] [Related]
7. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.
Yu Z; Cai R; Chang L; Qiu Y; Chen X; Chen Q; Ma G; Jin Y; Lin X
J Dermatol; 2019 May; 46(5):376-382. PubMed ID: 30916822
[TBL] [Abstract][Full Text] [Related]
8. [Infantile hemangioma: a new indication for propranolol? Retrospective study: a case-series of 25 infants].
Yilmaz L; Dangoisse C; Semaille P
Rev Med Brux; 2015; 36(1):3-9. PubMed ID: 25856965
[TBL] [Abstract][Full Text] [Related]
9. Initial experiences with propranolol treatment of infantile hemangiomas: report of three cases.
Halilbasic A; Hotic N; Husaric E; Rahmanovic E; Halilbasic M; Husaric S
Med Arh; 2011; 65(6):380-2. PubMed ID: 22299307
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment.
Li L; Yu L; Xu Z; Wei L; Zhang B; Han X; Sun Y; Ma L
J Cosmet Dermatol; 2023 Dec; 22(12):3369-3374. PubMed ID: 37313653
[TBL] [Abstract][Full Text] [Related]
11. Use of the Hemangioma Severity Scale to facilitate treatment decisions for infantile hemangiomas.
Moyakine AV; Herwegen B; van der Vleuten CJM
J Am Acad Dermatol; 2017 Nov; 77(5):868-873. PubMed ID: 28818436
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase.
Vivas-Colmenares GV; Bernabeu-Wittel J; Alonso-Arroyo V; Matute de Cardenas JA; Fernandez-Pineda I
Pediatr Dermatol; 2015; 32(3):348-52. PubMed ID: 25721095
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: Are we closer to understand the mechanism of action of propranolol on hemangiomas?
Babiak-Choroszczak L; Giżewska-Kacprzak K; Gawrych E; Fischer K; Walecka A; Puchalska-Niedbał L; Rajewska-Majchrzak J; Bagłaj M
Adv Clin Exp Med; 2018 May; 27(5):703-710. PubMed ID: 29790692
[TBL] [Abstract][Full Text] [Related]
14. The use of propranolol for complicated infantile hemangiomas.
Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
[TBL] [Abstract][Full Text] [Related]
15. Expression of β-Adrenergic Receptor Subtypes in Proliferative, Involuted, and Propranolol-Responsive Infantile Hemangiomas.
Phillips JD; Zhang H; Wei T; Richter GT
JAMA Facial Plast Surg; 2017 Mar; 19(2):102-107. PubMed ID: 27737446
[TBL] [Abstract][Full Text] [Related]
16. [Infantile hemangioma and propranolol: a therapeutic "revolution". Literature review].
Yilmaz L; Dangoisse C; Semaille P
Rev Med Brux; 2013; 34(6):479-84. PubMed ID: 24505868
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in children with infantile hemangioma: a case control study.
Wang C; Li Y; Xiang B; Xiong F; Li K; Yang K; Chen S; Ji Y
Health Qual Life Outcomes; 2017 Nov; 15(1):221. PubMed ID: 29145889
[TBL] [Abstract][Full Text] [Related]
18. [Propranolol in infantile hemangiomas].
Léauté-Labrèze C
Arch Pediatr; 2015 Apr; 22(4):452-5. PubMed ID: 25753275
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis.
Mazereeuw-Hautier J; Hoeger PH; Benlahrech S; Ammour A; Broue P; Vial J; Ohanessian G; Léauté-Labrèze C; Labenne M; Vabres P; Rössler J; Bodemer C
J Pediatr; 2010 Aug; 157(2):340-2. PubMed ID: 20488455
[TBL] [Abstract][Full Text] [Related]
20. Propranolol for infantile hemangioma (PINCH): an open-label trial to assess the efficacy of propranolol for treating infantile hemangiomas and for determining the decline in heart rate to predict response to propranolol.
Sondhi V; Patnaik SK
J Pediatr Hematol Oncol; 2013 Oct; 35(7):493-9. PubMed ID: 23929318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
